Metropolitan Life Insurance Company (MetLife)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,256
Closed -$674K 2819
2021
Q4
$674K Sell
6,256
-11
-0.2% -$1.19K 0.01% 1228
2021
Q3
$686K Buy
+6,267
New +$686K 0.01% 1229
2021
Q2
Sell
-13,420
Closed -$1.24M 2965
2021
Q1
$1.24M Sell
13,420
-580
-4% -$53.4K 0.02% 795
2020
Q4
$1.02M Sell
14,000
-275
-2% -$20.1K 0.02% 868
2020
Q3
$1.11M Buy
14,275
+486
+4% +$37.8K 0.02% 682
2020
Q2
$766K Buy
13,789
+8,301
+151% +$461K 0.01% 904
2020
Q1
$163K Sell
5,488
-48
-0.9% -$1.42K ﹤0.01% 1713
2019
Q4
$200K Buy
5,536
+56
+1% +$2.03K ﹤0.01% 1926
2019
Q3
$149K Sell
5,480
-51,225
-90% -$1.39M ﹤0.01% 2080
2019
Q2
$1.36M Hold
56,705
0.02% 714
2019
Q1
$1.5M Buy
56,705
+1,749
+3% +$46.2K 0.03% 640
2018
Q4
$1.07M Buy
54,956
+1,236
+2% +$24.2K 0.02% 770
2018
Q3
$1.05M Buy
+53,720
New +$1.05M 0.02% 905
2015
Q1
Sell
-49,867
Closed -$643K 2545
2014
Q4
$643K Buy
+49,867
New +$643K ﹤0.01% 1594
2014
Q3
Sell
-46,364
Closed -$733K 2765
2014
Q2
$733K Hold
46,364
0.01% 1559
2014
Q1
$701K Hold
46,364
﹤0.01% 1582
2013
Q4
$353K Buy
46,364
+2,807
+6% +$21.4K ﹤0.01% 2062
2013
Q3
$147K Buy
+43,557
New +$147K ﹤0.01% 2628